IZOIzotropic Corporation

CNQ · CA · Healthcare · Diagnostics & Research · izocorp.com

0.2500CAD-3.85%Mkt Cap: 12.56M $P/E: —25d ago

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of tar…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap12.56M $

Enterprise Value14.33M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-2.29M $

Revenue/Share—

Last Price0.2500 CAD

Fiscal Year EndApr 2025

MR QuarterJan 2026

Employees—

CountryCA

SectorHealthcare

IndustryDiagnostics & Research

ISINCA46604F1099

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-8.02

EV/Revenue—

P/S—

P/B-3.10

EPS (TTM)-0.03

EPS (Forward)—

52W Range

0.190020% of range0.4900

52W High0.4900 CAD

52W Low0.1900 CAD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE64.62%

ROA-757.05%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-463.34K $

CapEx (TTM)830 $

FCF Margin—

FCF Yield-5.70%

Net Debt2.02M $

Net Debt/EBITDA-1.13

Balance Sheet

Debt/Equity-0.57

Current Ratio0.10

Quick Ratio0.06

Book Value/Sh-0.0790 CAD

Cash/Share0.0050 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.69.82M

Float63.40M

Insiders7.86%

Institutions0.00%

Short Interest

Short Ratio0.2d

Short % Out.0.01%

Shares Short400

Short (prev mo.)16.73K

Technical

SMA 500.2518 (-0.7%)

SMA 2000.2677 (-6.6%)

Beta2.42

S&P 52W Chg18.16%

Avg Vol (30d)28.07K

Avg Vol (10d)23.55K

Technical Indicators

RSI (14)47.8

MACD-0.0006

MACD Signal-0.0015

MACD Hist.+0.0009

BB Upper0.2826 CAD

BB Middle0.2562 CAD

BB Lower0.2299 CAD

BB Width20.55%

ATR (14)0.0140 CAD

Vol Ratio (20d)0.23x